Skip to main content
. 2020 Jan 23;46(5):993–1004. doi: 10.1007/s00068-020-01304-5

Table 1.

Included cohort studies about prevalence of malnutrition and its effects on outcomes in trauma patients in this review (n = 10)

References Year Country Design n Male (%) Age in years Nutritional assessment tool Prevalence MN on admission (unless indicated otherwise) (%) ARM (%) Mortality Length of stay in days Complications
Wilson et al. [36] 2019 United States Prospective cohort study 377 50.9

73.70m

 ± SD 12.73

Visceral proteins

Hypoalbuminaemia: 17.5

Low TLC: 62.3

Hypoalbuminaemia: OR2.22 95% CI 1.26–3.92

TLC: n/a

Hypoalbuminaemia: r = − 0.14, p = 0.024

TLC:n/a

 ≥ 1 adverse event associated with MN, p < 0.001
Wilson et al. [34] 2019 United States Retrospective cohort study 5673 43.8

46.69m

 ± SD 13.62

Visceral proteins Hypoalbuminaemia: 29.6

WN: 0.4%,

MN: 3.2%,

RR 4.86,

95% CI 2.66–8.87

WN: 3.57 (± SD 5.0)

MN: 7.5 (± SD 10.45)

p < 0.001

 ≥ 1 adverse event RR 1.46 95% CI 1.30–1.64;

Sepsis RR 1.99 95% CI 1.03–3.86;

Unplanned intubation RR 2.95 95% CI 1.49–5.84;

Reoperation RR 1.52 95% CI 1.11–2.07;

Readmission RR 2.0 95% CI 1.55–2.57

Wintermeyer et al. [35] 2019 Germany Prospective cohort study 1642

57.8m

 ± SD 16.6

NRS

Overall: 18.3

Geriatric trauma: 35.6

 ≥ 1 adverse event associated with ARM, p < 0.01; quality of life negatively associated with ARM, p < 0.01
Ihle et al. [33] 2017 Germany Prospective cohort study 521 56.2

53.9m

 ± SD 18.1

NRS 19.2

NRS ≥ 3 (ARM): 16 ± SD 12

NRS < 3 (WN):

11 ± SD 10

 ≥ 1 adverse event associated with ARM, p < 0.001
Müller et al. [26] 2017 Switzerland Non-comparative prospective cohort study 169 42.6

79.7m

 ± SD 6.5

MNA 7.1 49.1
Goisser et al. [27] 2015 Germany Non-comparative retrospective cohort study 97 20.6

84.0m

 ± SD 5.0

MNA

(long form)

17.0 38.0

WN:13%,

ARM: 21%,

MN: 0%,

p = 0.120

WN:11med

IQR 10–16, ARM:12med

IQR 9–17,

MN:10med

IQR 7–15,

p = 0.388

WN: 86%,

ARM: 97%,

MN: 100%,

p = 0.095

Chakravarty et al. [28] 2013 India Non-comparative prospective cohort study 61 78.7 SGA 15.0
Banks et al. [29] 2010 Ireland Non-comparative prospective cohort study 30 37.0

78.5med

IQR 68–85

MNA 60.0
Dhandapani et al. [25] 2007 India Non-comparative prospective cohort study 61 92.0

35.4m

 ± SD not reported

Anthropometric measurements

Clinical features of pedal edema, cheilosis, skeletal prominence, xerosis, gum bleed:

Week 1: 45.0

Week 3: 76.0

Goiburu et al. [10] 2006 Paraguay Non-comparative prospective cohort study 161 94.0

27.0med

IQR 14–92

SGA 40.0 RR 4; 95% CI 1–15  > 14 days RR 2.3; 95% CI 1.2–4.7

RR 2.9;

95% CI 1.4–5.8

Compan et al. [30] 1999 France Non-comparative prospective cohort study 299 33.0

82.9m

 ± SD 7.0

MNA 24.7 Longer stay associated with MN, p not reported Death during hospitalization associated with MN, p < 0.0001
McClave et al. [31] 1992 United States Non-comparative prospective cohort study Visceral proteins Anthropometric measurements Low visceral proteins (albumin, transferrin, TLC): 17.6%, Underweight: 20.6%, Mix: 15.6%

OR 4.04;

p < 0.05

OR 1.29;

p < 0.05

Sepsis: OR 2.64; p < .05; Nosocomial infections: OR 2.26; p < 0.05
Kaufman et al. [32] 1987 United States Non-comparative prospective cohort study 76 Visceral proteins Anthropometric measurements Albumin, transferrin, TLC, and others: not defined -

MN Malnourished, ARM At risk for malnutrition, WN Well−nourished, NRS Nutritional Risk Screening, MNA Mini Nutritional Assessment, SGA Subjective Global Assessment scale, TLC Total lymphocyte count, SD Standard deviation, IQR Interquartile range, RR relative risk, C: confidence interval, OR adjusted odds ratio

*n refers to the number of trauma patients in the study

m mean

med median